Montelast L(Morepen) is a prescription medicine that is available as a Tablet. Other than this, Montelast L(Morepen) has some other therapeutic uses, which have been discussed ahead.
The right dosage of Montelast L(Morepen) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Montelast L(Morepen) include Headache, Stomach ache, Joint pain. Usually, these side effects of Montelast L(Morepen) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Montelast L(Morepen)'s effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Montelast L(Morepen) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Montelast L(Morepen) related warnings section.
Montelast L(Morepen) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions.
Drug interactions for Montelast L(Morepen) have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Montelast L(Morepen), it is important to know that it is not safe while driving, and is not habit-forming.
Montelast L(Morepen) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Montelast L(Morepen) safe for pregnant women?
Pregnant women may get severe side effects after taking Montelast L. If you are pregnant, do not take Montelast L without a doctor's advice.
Is the use of Montelast L(Morepen) safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Montelast L. So it is adviced to consult the doctor before using it.
What is the effect of Montelast L(Morepen) on the Kidneys?
Information about safety of Montelast L for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Montelast L(Morepen) on the Liver?
There is no research available on the side effects of Montelast L on the liver. Therefore, its impact is unknown.
What is the effect of Montelast L(Morepen) on the Heart?
Side effects of Montelast L on heart are unknown because research on this has not been conducted yet.
Montelast L(Morepen) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Montelast L(Morepen) unless your doctor advises you to do so -
Is this Montelast L(Morepen) habit forming or addictive?
Montelast L(Morepen) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Montelast L(Morepen) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Montelast L(Morepen) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Montelast L(Morepen) for mental disorders.
Interaction between Food and Montelast L(Morepen)
Information is not available on the interaction of any foods with Montelast L(Morepen), due to a lack of research on this.
Interaction between Alcohol and Montelast L(Morepen)
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Montelast L(Morepen).
Take Montelast L as directed by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
Montelast L is the brand name of levocetirizine. It is a prescription drug that belongs to the class of medications called antihistamine (H1 receptor blocker). It is used in the treatment of allergic rhinitis, urticaria, runny nose, itching eyes/nose, sneezing and other types of allergies.
Discontinuation of Montelast L on your own can cause unwanted side effects and withdrawal symptoms. You are recommended to always consult a doctor before discontinuing this medicine.
Absorption of Montelast L is not affected by food and hence can be taken with or without food. Preferably it should be taken in the evening. However, you are recommended to take it as per the doctor's instructions.
Yes, Montelast L can be taken for relieving symptoms of a cold. However, it is best to consult your doctor for the right line of treatment for the cold.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
Product Index [Internet]: MONTAIR LC & MONTAIR LC KID DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride ). Ciplamed
Highlights of Prescribing Information [Internet]: XYZAL® (levocetirizine dihydrochloride) tablets . Initial U.S. Approval: 19952007
Smpc [Internet]: montelukast sodium. Aurobindo Pharma
Package leaflet Information for the patient [Internet]: Xyzal 0.5 mg/ml oral solution. UCB Pharma Ltd